Karim Boudjema is an expert in Surgery at Centre Hospitalier Universitaire de Rennes (France). As of October 2026, ScienceLeadR ranks Karim Boudjema in the top 1% of experts worldwide for Liver Transplantation, Tissue Transplantation and Carcinoma. Karim Boudjema has authored 488 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 1,373 (community average: 125). How the SLR is computed.

LeadR Profile

1 373 ScienceLeadR Reputation 1373
Network Map

Surgery

Subspecialties: Hepatology - Transplantation - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026

Source: PubMed

l'Hôpital Pontchaillou

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 488

Citations

Citations: 17 156 1st author: 38 Last author: 106 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Combined versus staged resection of synchronous rectal cancer liver metastases: national target trial emulation.
PMID 42929025 — neoplasms, liver, liver neoplasms, neoplasm metastasis, rectal neoplasms, therapeutics, general surgery
Br J Surg20260
Hypothermic Oxygenated Perfusion Versus Static Cold Storage in Liver Transplantation: A Meta- Analysis of Randomized Trials.
PMID 42717689 — liver transplantation, cold temperature, graft survival, liver, reperfusion injury, transplants, transplantation
Clin Transplant20260
Guidelines 2025: perioperative management of adult patients undergoing liver resection.
PMID 42567152 — anesthesia, liver
Anaesth Crit Care Pain Med20260
[Steatosis and steatohepatitis: a risk factor for complications after liver resection].
PMID 42083845 — liver transplantation, non-alcoholic fatty liver disease, liver, risk factors, transplants, metabolic syndrome, transplantation
Rev Prat20260
Performance of Predefined Viability Criteria During Prolonged End-Ischemic Normothermic Perfusion of Brain-Dead Donor Liver Grafts.
PMID 42033268 — liver transplantation, brain, graft survival, liver, brain death, transplants, transplantation
Clin Transplant20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Director: 3

By phase:

N/A 8
Phase 3 7
Phase 2 2
Phase 2/Phase 3 1

By status:

Completed 11
Terminated 4
Not yet recruiting 1
Recruiting 1
Withdrawn 1

By type:

Interventional 16
Observational 2

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 2
multicentric5to9 7
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 — liver transplantation, carcinoma, hepatocellular, liver, hepatectomy, transplantation, carcinoma
N/ANot yet recruiting2023

LeadR Networks

Main global connection map